Additionally, following three weeks growth in murine xenograft models, CBS siRNA knockdown in breast cancer cells resulted in lower tumor volumes compared to cells without knockdown (8 mm2 vs. 125 mm2). This evidence concerns the gene CBS and breast cancer.